Engleman honored with 2026 AABB Landsteiner-Alter Award The Association for the Advancement of Blood & Biotherapies (AABB) has selected Edgar Engleman, M.D., as the recipient of the prestigious 2026 Landsteiner-Alter Award, the organization’s highest scientific honor. This annual recognition celebrates individuals whose original research has profoundly influenced the fields of